Plaintiffs Get AbbVie Medical Fraud Case Remanded to State Court

On September 18, 2018, Lieff Cabraser and California Insurance Commissioner Dave Jones sued AbbVie, Inc. for violations of the Insurance Frauds Prevention Act (“IFPA”) by providing kickbacks to healthcare providers throughout California relating to sale of the immunosuppressive drug Humira. Defendant AbbVie removed the case to federal court, arguing that the State of California should

2019-08-12T11:48:51+00:00August 12th, 2019|Whistleblower Law|

California Department of Insurance Intervenes in Lieff Cabraser’s Lawsuit Against AbbVie Alleging Kickbacks and Improper Marketing of Top-Selling Drug Humira

Joint Complaint Filed Under the California Insurance Frauds Prevention Act On September 18, 2018, Lieff Cabraser and California Insurance Commissioner Dave Jones sued AbbVie, Inc. for violations of the Insurance Frauds Prevention Act (“IFPA”) by providing kickbacks to healthcare providers throughout California relating to sale of the immunosuppressive drug Humira. Humira, used to treat arthritis,

2018-09-18T13:08:35+00:00September 18th, 2018|Consumer Fraud, Whistleblower Law|